FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

11550511000001100: Clasteon 400mg capsules (Kent Pharma (UK) Ltd) 30 capsule 3 x 10 capsules (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1873741000001118 Clasteon 400mg capsules (Kent Pharma (UK) Ltd) 30 capsule 3 x 10 capsules en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1873751000001115 Clasteon 400mg capsules (Kent Pharma (UK) Ltd) 30 capsule 3 x 10 capsules (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clasteon 400mg capsules (Kent Pharma (UK) Ltd) 30 capsule 3 x 10 capsules Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Clasteon 400mg capsules (Kent Pharma (UK) Ltd) 30 capsule 3 x 10 capsules Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Clasteon 400mg capsules (Kent Pharma (UK) Ltd) 30 capsule 3 x 10 capsules Is a Sodium clodronate 400mg capsules 30 capsule true Inferred relationship Existential restriction modifier
Clasteon 400mg capsules (Kent Pharma (UK) Ltd) 30 capsule 3 x 10 capsules Is pack of Clasteon 400mg capsules (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Clasteon 400mg capsules (Kent Pharma (UK) Ltd) 30 capsule 3 x 10 capsules Has active ingredient Clodronic acid false Inferred relationship Existential restriction modifier
Clasteon 400mg capsules (Kent Pharma (UK) Ltd) 30 capsule 3 x 10 capsules Has active ingredient Clodronate disodium false Inferred relationship Existential restriction modifier
Clasteon 400mg capsules (Kent Pharma (UK) Ltd) 30 capsule 3 x 10 capsules Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Clasteon 400mg capsules (Kent Pharma (UK) Ltd) 30 capsule 3 x 10 capsules Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Clasteon 400mg capsules (Kent Pharma (UK) Ltd) 30 capsule 3 x 10 capsules VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Clasteon 400mg capsules (Kent Pharma (UK) Ltd) 30 capsule 3 x 10 capsules VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Clasteon 400mg capsules (Kent Pharma (UK) Ltd) 30 capsule 3 x 10 capsules Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Clasteon 400mg capsules (Kent Pharma (UK) Ltd) 30 capsule 3 x 10 capsules Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Clasteon 400mg capsules (Kent Pharma (UK) Ltd) 30 capsule 3 x 10 capsules Has AMP Clasteon 400mg capsules (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Clasteon 400mg capsules (Kent Pharma (UK) Ltd) 30 capsule 3 x 10 capsules Has specific active ingredient Clodronate disodium true Inferred relationship Existential restriction modifier
Clasteon 400mg capsules (Kent Pharma (UK) Ltd) 30 capsule 3 x 10 capsules Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Clasteon 400mg capsules (Kent Pharma (UK) Ltd) 30 capsule 3 x 10 capsules Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start